Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
Lee
Agnes Y Y
AY
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D017985:Dalteparin / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D017985:Dalteparin